US Patent 11013849 was granted and issued on 25 May 2021.
A closer look reveals that there is the added word of “Cell” in its title.
US Patent 11013849 is especially important as the third patent in the series. The reason for this is that the claims contained therein are much more specific to the design elements and specifications of the exposure cell, or cells. Additionally, the clinical aspects regarding the critical need for the timely treatment of severe carbon monoxide poisoning as a definitive countermeasure are explicitly described.
Other aspects include strategies for mitigating the transfer of heat to the blood due the absorption of the light energy.
Naturally, all of the specific details are included in its publication, which can be found here.
